… Three recent population PK analyses favored models with … different piperacillin dose levels
that was analyzed by population PK modeling. Also, the impact of the saturation of piperacillin …

… known data examining the population pharmacokinetics of piperacillin in critically ill patients
… different pharmacokinetic parameters than those observed in other patient populations, …

… were to describe the PK of piperacillin in the presence of tazobactam and to characterize
its pharmacodynamic profile. Through population PK modeling, the PK model that best …

… PK profile for piperacillin given at 4 g every 8 h in 22 septic patients admitted to a medical
ward. Piperacillin … /liter), and the following PK/pharmacodynamic (PD) targets were evaluated: …

… piperacillin and tazobactam pharmacokinetic parameters during critical illness and the lack
of population pharmacokinetic … a better understanding of piperacillin/tazobactam disposition …

… PK in healthy volunteers in a controlled clinical study. Therefore, we compared the population
PK and pharmacodynamics (PD) of piperacillin … ) who each received 4 g piperacillin as a 5-…

… The protein bindings of piperacillin and tazobactam in … MIC and result in pharmacodynamic
and pharmacoeconomic … to explore the population pharmacokinetics of piperacillin and …

… concentration-time profiles for piperacillin and tazobactam … concentration-time profiles of
piperacillin and tazobactam for … this study to build the population pharmacokinetic model (n = 12)…

… This study aimed to characterize the population pharmacokinetics (PKs) of piperacillin and
… Forty-eight patients treated with piperacillin/tazobactam were recruited. Five blood samples …

… of piperacillin/tazobactam in hospitalized obese and … -state population pharmacokinetics of
piperacillin and tazobactam, … evaluate the pharmacodynamics of piperacillin and tazobactam …